For the 2025 Case Based Panel Discussions, a panel of oncologists consisting of Dr. Isabel Preeshagul, Dr. Deborah Doroshow and Dr. Christine Garcia...
The 2025 Targeted Therapies in Lung Cancer Patient Forum was a live, virtual, interactive patient education event presented in March 2025 and led by...
The panel discusses the current standard of care for patients with head and neck cancer who need surgery, the findings of the Keynote 689 study, which...
Como parte de la Videoteca de Cáncer de Pulmón en Español 2025, oncólogos expertos discuten las opciones de tratamiento y la información más emergente...
In these videos, Dr. Jared Weiss gives a brief overview of NUT Carcinoma, discusses treatment options and possible future treatment. To watch the...
The journey to conquer lung cancer is paved with scientific discovery, and the identification of the EGFR and ALK genes as crucial players marks a significant milestone. Unraveling how mutations in these seemingly small segments of our DNA can unleash the destructive force of cancer has opened up exciting new therapeutic avenues. This exploration delves into the cutting-edge world of EGFR and ALK-targeted therapies, highlighting the progress made and the ongoing quest for even more effective and personalized strategies to combat this formidable disease.
View the full ON-Demand Video now! This live, virtual, interactive patient education event included presentations and panel discussions covering...
Don't let the word "small" deceive you. Small cell lung cancer (SCLC) casts a long shadow, impacting lives with its aggressive nature and the complexities of its treatment. But while the challenges are real, so is the progress. Breakthroughs in small cell lung cancer treatment offer hope. Immunotherapy plus chemo-radiation improves survival by 22 months. Screening catches it early.
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.